15-72345454-T-C

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000520.6(HEXA):​c.1518A>G​(p.Glu506Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.979 in 1,614,144 control chromosomes in the GnomAD database, including 778,550 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 62364 hom., cov: 34)
Exomes 𝑓: 0.99 ( 716186 hom. )

Consequence

HEXA
NM_000520.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: -0.293
Variant links:
Genes affected
HEXA (HGNC:4878): (hexosaminidase subunit alpha) This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 15-72345454-T-C is Benign according to our data. Variant chr15-72345454-T-C is described in ClinVar as [Benign]. Clinvar id is 93191.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-72345454-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.293 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.992 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HEXANM_000520.6 linkc.1518A>G p.Glu506Glu synonymous_variant Exon 13 of 14 ENST00000268097.10 NP_000511.2 P06865-1A0A0S2Z3W3
HEXANM_001318825.2 linkc.1551A>G p.Glu517Glu synonymous_variant Exon 13 of 14 NP_001305754.1 P06865H3BP20B4DVA7
HEXANR_134869.3 linkn.1303A>G non_coding_transcript_exon_variant Exon 11 of 11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HEXAENST00000268097.10 linkc.1518A>G p.Glu506Glu synonymous_variant Exon 13 of 14 1 NM_000520.6 ENSP00000268097.6 P06865-1
ENSG00000260729ENST00000379915.4 linkn.600A>G non_coding_transcript_exon_variant Exon 5 of 16 2 ENSP00000478716.1 A0A087WUJ7

Frequencies

GnomAD3 genomes
AF:
0.889
AC:
135239
AN:
152172
Hom.:
62345
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.613
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.962
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
0.997
Gnomad MID
AF:
0.978
Gnomad NFE
AF:
0.998
Gnomad OTH
AF:
0.921
GnomAD3 exomes
AF:
0.971
AC:
244012
AN:
251424
Hom.:
119593
AF XY:
0.979
AC XY:
133012
AN XY:
135894
show subpopulations
Gnomad AFR exome
AF:
0.605
Gnomad AMR exome
AF:
0.981
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad SAS exome
AF:
0.999
Gnomad FIN exome
AF:
0.998
Gnomad NFE exome
AF:
0.998
Gnomad OTH exome
AF:
0.988
GnomAD4 exome
AF:
0.988
AC:
1444272
AN:
1461854
Hom.:
716186
Cov.:
51
AF XY:
0.989
AC XY:
719550
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.600
Gnomad4 AMR exome
AF:
0.979
Gnomad4 ASJ exome
AF:
1.00
Gnomad4 EAS exome
AF:
1.00
Gnomad4 SAS exome
AF:
0.999
Gnomad4 FIN exome
AF:
0.998
Gnomad4 NFE exome
AF:
0.999
Gnomad4 OTH exome
AF:
0.975
GnomAD4 genome
AF:
0.889
AC:
135312
AN:
152290
Hom.:
62364
Cov.:
34
AF XY:
0.892
AC XY:
66419
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.613
Gnomad4 AMR
AF:
0.962
Gnomad4 ASJ
AF:
1.00
Gnomad4 EAS
AF:
1.00
Gnomad4 SAS
AF:
0.999
Gnomad4 FIN
AF:
0.997
Gnomad4 NFE
AF:
0.998
Gnomad4 OTH
AF:
0.922
Alfa
AF:
0.961
Hom.:
59319
Bravo
AF:
0.873
Asia WGS
AF:
0.977
AC:
3397
AN:
3478
EpiCase
AF:
0.998
EpiControl
AF:
0.997

ClinVar

Significance: Benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jun 18, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Tay-Sachs disease Benign:5
Jun 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 29, 2017
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:5
Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 05, 2018
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 18, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
16
DANN
Benign
0.83
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4777502; hg19: chr15-72637795; API